Epic Research Update : Ranbaxy Laboratories

Ranbaxy Laboratories, one of the India’s largest pharmaceutical company, has launched Infimab, the first ‘Remicade (Infliximab) biosimilar in India. The product was launched at the Indian Rheumatology Association Conference (IRACON) in Chandigarh, in the presence of over a thousand rheumatologists and doctors from around the country.



Real Time News & Trading Trends Keep Liking #EpicResearch







Facebook – Twitter – YouTube – Pinterest –Linkedin – Google+







For more information ✆ – 0731-6642300 or Visithttp://ift.tt/1k8NnLH







Real Time News & Trading Trends Keep Liking #EpicResearch

Facebook – Twitter – YouTube – Pinterest –Linkedin – Google+

For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips